| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2025 | Mar, 2025 | Mar, 2025 | Mar, 2025 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Anteris Technologies Global Corp (AVR)
4.70 x 1 5.40 x 10
Post-market by (Cboe BZX)
5.12 -0.06 (-1.16%) 03/24/25 [NASDAQ]
4.70 x 1 5.40 x 10
Post-market 5.12 unch (unch) 16:00 ET
for Mon, Mar 24th, 2025
Anteris Technologies Global Corp. is involved in designing, developing and commercializing cutting-edge medical devices to restore healthy heart function. The company's lead product includes DurAVR(R). Anteris Technologies Global Corp. is based in BRISBANE, Australia.
Fiscal Year End Date: 12/31